EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点
Gespeichert in:
Veröffentlicht in: | 上海交通大学学报(医学版) 2019-03, Vol.39 (3), p.221-223 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | chi |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 223 |
---|---|
container_issue | 3 |
container_start_page | 221 |
container_title | 上海交通大学学报(医学版) |
container_volume | 39 |
creator | 陆舜·研究组 |
description | |
doi_str_mv | 10.3969/j.issn.1674-8115.2019.03.001 |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour</sourceid><recordid>TN_cdi_wanfang_journals_shdeykdxxb201903002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>shdeykdxxb201903002</wanfj_id><sourcerecordid>shdeykdxxb201903002</sourcerecordid><originalsourceid>FETCH-LOGICAL-s1062-a07a49636e13f82b66d0b47284866f0ed927624c26fe345db4dd47faddbbd1dc3</originalsourceid><addsrcrecordid>eNo9j01LAkEch-dQkJjfolvs9p8XZ3aOrawWCIHUWXac3dJig4bIbiUFCUbRwd7s1CHoFAVR-nVyxr5FRdHpB8_hefghNIfBp5LLhZbfNCbzMRfMCzAu-gSw9IH6AHgK5f75DCoY01QAgktKBORQGFXKtfFFL6qFIXEPp-5l5B4Px2dXdtC1g1t7cv7xNpx0hu66Zzv3k4Nj239yN0f2eeT6l593r67zPoum03jLJIW_zaO1crRaWvKqK5Xl0mLVMxg48WIQMZOc8gTTNCCKcw2KCRKwgPMUEi2J4IQ1CE8TyopaMa2ZSGOtldJYN2gezf969-IsjbP1emt7dyf7LtbNhk72N3W7rX5-AwUg9AvbsmOe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点</title><source>DOAJ Directory of Open Access Journals</source><creator>陆舜·研究组</creator><creatorcontrib>陆舜·研究组</creatorcontrib><identifier>ISSN: 1674-8115</identifier><identifier>DOI: 10.3969/j.issn.1674-8115.2019.03.001</identifier><language>chi</language><ispartof>上海交通大学学报(医学版), 2019-03, Vol.39 (3), p.221-223</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/shdeykdxxb/shdeykdxxb.jpg</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>陆舜·研究组</creatorcontrib><title>EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点</title><title>上海交通大学学报(医学版)</title><issn>1674-8115</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9j01LAkEch-dQkJjfolvs9p8XZ3aOrawWCIHUWXac3dJig4bIbiUFCUbRwd7s1CHoFAVR-nVyxr5FRdHpB8_hefghNIfBp5LLhZbfNCbzMRfMCzAu-gSw9IH6AHgK5f75DCoY01QAgktKBORQGFXKtfFFL6qFIXEPp-5l5B4Px2dXdtC1g1t7cv7xNpx0hu66Zzv3k4Nj239yN0f2eeT6l593r67zPoum03jLJIW_zaO1crRaWvKqK5Xl0mLVMxg48WIQMZOc8gTTNCCKcw2KCRKwgPMUEi2J4IQ1CE8TyopaMa2ZSGOtldJYN2gezf969-IsjbP1emt7dyf7LtbNhk72N3W7rX5-AwUg9AvbsmOe</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>陆舜·研究组</creator><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20190301</creationdate><title>EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点</title><author>陆舜·研究组</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s1062-a07a49636e13f82b66d0b47284866f0ed927624c26fe345db4dd47faddbbd1dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>陆舜·研究组</creatorcontrib><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>上海交通大学学报(医学版)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>陆舜·研究组</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点</atitle><jtitle>上海交通大学学报(医学版)</jtitle><date>2019-03-01</date><risdate>2019</risdate><volume>39</volume><issue>3</issue><spage>221</spage><epage>223</epage><pages>221-223</pages><issn>1674-8115</issn><doi>10.3969/j.issn.1674-8115.2019.03.001</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1674-8115 |
ispartof | 上海交通大学学报(医学版), 2019-03, Vol.39 (3), p.221-223 |
issn | 1674-8115 |
language | chi |
recordid | cdi_wanfang_journals_shdeykdxxb201903002 |
source | DOAJ Directory of Open Access Journals |
title | EGFR和ERBB2种系突变有望成为肺癌患者新的治疗靶点 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T13%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EGFR%E5%92%8CERBB2%E7%A7%8D%E7%B3%BB%E7%AA%81%E5%8F%98%E6%9C%89%E6%9C%9B%E6%88%90%E4%B8%BA%E8%82%BA%E7%99%8C%E6%82%A3%E8%80%85%E6%96%B0%E7%9A%84%E6%B2%BB%E7%96%97%E9%9D%B6%E7%82%B9&rft.jtitle=%E4%B8%8A%E6%B5%B7%E4%BA%A4%E9%80%9A%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5%EF%BC%88%E5%8C%BB%E5%AD%A6%E7%89%88%EF%BC%89&rft.au=%E9%99%86%E8%88%9C%C2%B7%E7%A0%94%E7%A9%B6%E7%BB%84&rft.date=2019-03-01&rft.volume=39&rft.issue=3&rft.spage=221&rft.epage=223&rft.pages=221-223&rft.issn=1674-8115&rft_id=info:doi/10.3969/j.issn.1674-8115.2019.03.001&rft_dat=%3Cwanfang_jour%3Eshdeykdxxb201903002%3C/wanfang_jour%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_wanfj_id=shdeykdxxb201903002&rfr_iscdi=true |